AKOUSTIS TECHNOLOGIES, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 59 rows, 59 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2024-08-19: Reporting owner Cheema Kamran; Form 3; Security Stock Options (Right to buy); Transaction Holding.
- 2024-08-19: Reporting owner Cheema Kamran; Form 3; Security Stock Options (Right to buy); Transaction Holding.
- 2023-11-06: Reporting owner Denbaars Steven; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-11-06: Reporting owner Petock Michelle; Form 4; Security Stock Options (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-08-19 holding as of filing | Cheema Kamran Officer (Interim CEO) | 3 | Stock Options (Right to buy) Derivative · Direct | Holding | $10.02 exercise price | 2024-08-19 | ||
| 2024-08-19 holding as of filing | Cheema Kamran Officer (Interim CEO) | 3 | Stock Options (Right to buy) Derivative · Direct | Holding | $8.09 exercise price | 2024-08-19 | ||
| 2023-11-06 | Denbaars Steven Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +76,500 76,500 owned after | $0.59 exercise price | 2023-11-08 | |
| 2023-11-06 | Petock Michelle Director | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +185,000 185,000 owned after | $0.59 exercise price | 2023-11-08 | |
| 2022-11-10 | McMahon Jeffrey Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +84,146 84,146 owned after | $3.45 exercise price | 2022-11-14 | |
| 2022-11-10 | RUDY SUZANNE B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +113,152 113,152 owned after | $3.45 exercise price | 2022-11-14 | |
| 2022-06-20 | Geiss Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $1.50 exercise price | 2022-06-21 | |
| 2022-02-17 | Geiss Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 20,000 owned after | $1.50 exercise price | 2022-02-22 | |
| 2022-02-14 | Denbaars Steven Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,013 24,719 owned after | $6.24 exercise price | 2022-02-15 | |
| 2022-02-10 | Boller Kenneth Officer (CFO) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.88 exercise price | 2022-02-22 | |
| 2022-02-10 | Shealy Jeffrey B. Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 45,000 owned after | $7.12 exercise price | 2022-02-14 | |
| 2021-09-09 | Shealy Jeffrey B. Director, Officer (Chief Executive Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $10.15 exercise price | 2021-09-10 | |
| 2021-08-27 | Boller Kenneth Officer (Interim CFO) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $9.99 exercise price | 2021-08-31 | |
| 2021-08-27 | Aichele David Officer (EVP of Business Development) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $9.99 exercise price | 2021-08-31 | |
| 2020-10-29 | McMahon Jeffrey Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +39,704 39,704 owned after | $8.54 exercise price | 2020-10-30 | |
| 2020-08-28 | Houlden Rohan Officer (Chief Product Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $8.11 exercise price | 2020-09-01 | |
| 2020-08-28 | Aichele David Officer (EVP of Business Development) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $8.11 exercise price | 2020-09-01 | |
| 2020-08-28 | Shealy Jeffrey B. Director, Officer (Chief Executive Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $8.11 exercise price | 2020-09-01 | |
| 2020-08-28 | Boller Kenneth Officer (Interim CFO) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $8.11 exercise price | 2020-09-01 | |
| 2019-12-20 | Shealy Jeffrey B. Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $7.98 exercise price | 2019-12-26 | |
| 2018-11-27 | Shealy Jeffrey B. Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Options (Right to buy) Derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $5.00 exercise price | 2018-11-27 | |
| 2018-11-23 | Houlden Rohan Officer (Chief Product Officer) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $4.76 exercise price | 2018-11-27 | |
| 2018-11-23 | Aichele David Officer (VP of Business Development) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $4.76 exercise price | 2018-11-27 | |
| 2018-11-23 | Shealy Jeffrey B. Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Options (Right to buy) Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $4.76 exercise price | 2018-11-27 | |
| 2018-11-23 | Boller Kenneth Officer (Interim CFO) | 4 | Stock Options (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $4.76 exercise price | 2018-11-27 | |
| 2018-11-19 holding as of filing | Houlden Rohan Officer (Chief Product Officer) | 3 | Stock Options (Right to buy) Derivative · Direct | Holding | $7.12 exercise price | 2018-11-19 | ||
| 2018-11-14 holding as of filing | Boller Kenneth Officer (Interim CFO) | 3 | Stock Options (Right to buy) Derivative · Direct | Holding | $6.35 exercise price | 2018-11-14 | ||
| 2018-11-14 holding as of filing | Boller Kenneth Officer (Interim CFO) | 3 | Stock Options (Right to buy) Derivative · Direct | Holding | $6.24 exercise price | 2018-11-14 | ||
| 2018-11-02 | Geiss Arthur Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $3.78 exercise price | 2018-11-09 | |
| 2018-11-02 | Geiss Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $4.07 exercise price | 2018-11-05 | |
| 2018-11-01 | Geiss Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,360 60,360 owned after | $4.07 exercise price | 2018-11-05 | |
| 2018-11-01 | Denbaars Steven Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,748 22,748 owned after | $4.07 exercise price | 2018-11-02 | |
| 2018-11-01 | MILLER STEVEN P Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,997 21,997 owned after | $4.07 exercise price | 2018-11-02 | |
| 2018-11-01 | McMahon Jeffrey Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +48,348 48,348 owned after | $4.07 exercise price | 2018-11-02 | |
| 2018-11-01 | RUDY SUZANNE B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,502 51,502 owned after | $4.07 exercise price | 2018-11-02 | |
| 2017-11-16 | Denbaars Steven Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,732 32,732 owned after | $6.24 exercise price | 2018-03-19 | |
| 2017-11-16 | RUDY SUZANNE B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,053 37,053 owned after | $6.24 exercise price | 2017-11-16 | |
| 2017-11-16 | MILLER STEVEN P Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +31,652 31,652 owned after | $6.24 exercise price | 2017-11-16 | |
| 2017-11-16 | McMahon Jeffrey Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,568 69,568 owned after | $6.24 exercise price | 2017-11-16 | |
| 2017-11-16 | Geiss Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +86,854 86,854 owned after | $6.24 exercise price | 2017-11-16 | |
| 2017-11-16 | Denbaars Steven Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,732 32,732 owned after | $6.24 exercise price | 2017-11-16 | |
| 2017-09-27 | Shealy Jeffrey Director, Officer (Chief Executive Officer), 10% Owner | 4/A | Stock Option (Right to Buy) Derivative · Indirect · By wife | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $7.12 exercise price | 2017-12-18 | |
| 2017-09-27 | KURTZWEIL JOHN T Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $7.12 exercise price | 2017-09-29 | |
| 2017-09-27 | Aichele David Officer (VP of Business Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $7.12 exercise price | 2017-09-29 | |
| 2017-09-27 | Shealy Jeffrey Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $7.12 exercise price | 2017-09-29 | |
| 2017-09-27 | Payne Cindy Other (Former Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $7.12 exercise price | 2017-09-29 | |
| 2017-09-27 | Geiss Arthur Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $7.12 exercise price | 2017-09-29 | |
| 2017-03-10 holding as of filing | Denbaars Steven Director | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | Denbaars Steven Director | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | Denbaars Steven Director | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | Denbaars Steven Director | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | McMahon Jeffrey Director | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | McMahon Jeffrey Director | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | McMahon Jeffrey Director | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | McMahon Jeffrey Director | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | Geiss Arthur Director, Officer (Co-Chairman of the Board) | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | Geiss Arthur Director, Officer (Co-Chairman of the Board) | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | Geiss Arthur Director, Officer (Co-Chairman of the Board) | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 | ||
| 2017-03-10 holding as of filing | Geiss Arthur Director, Officer (Co-Chairman of the Board) | 3 | Options (right to buy) Derivative · Direct | Holding | $1.50 exercise price | 2017-03-10 |